NDC 62541-406-10
PANCREAZE 149900 [USP'U]/1
PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE · CAPSULE, DELAYED RELEASE
Pancreaze is a prescription medication containing pancreatic enzymes that help digest fats, carbohydrates, and proteins in people whose pancreas cannot produce enough of these enzymes naturally. It is taken by mouth as a delayed-release capsule and is used to treat conditions like cystic fibrosis and chronic pancreatitis where enzyme replacement is needed.
Key Facts
- Brand Name
- PANCREAZE
- Generic Name
- PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE
- NDC Code (Package)
62541-406-10- NDC Code (Product)
62541-406- Manufacturer
- VIVUS LLC
- Strength
- 149900 [USP'U]/1
- Dosage Form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- BLA022523
- Marketing Start
- 07/01/2021
Recall History
No Recall HistoryView Full Drug Page
PANCREAZE — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.